1. Home
  2. FNWD vs FHTX Comparison

FNWD vs FHTX Comparison

Compare FNWD & FHTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Finward Bancorp

FNWD

Finward Bancorp

HOLD

Current Price

$43.66

Market Cap

187.1M

Sector

Finance

ML Signal

HOLD

Logo Foghorn Therapeutics Inc.

FHTX

Foghorn Therapeutics Inc.

BUY

Current Price

$2.03

Market Cap

111.1M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
FNWD
FHTX
Founded
1994
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
187.1M
111.1M
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
FNWD
FHTX
Price
$43.66
$2.03
Analyst Decision
Buy
Analyst Count
0
10
Target Price
N/A
★ $4.17
AVG Volume (30 Days)
7.7K
★ 1.2M
Earning Date
11-02-2026
11-04-2026
Dividend Yield
★ 1.10%
N/A
EPS Growth
N/A
★ 25.32
EPS
★ 1.00
N/A
Revenue
N/A
★ $30,909,000.00
Revenue This Year
$10.81
N/A
Revenue Next Year
$5.26
$15.98
P/E Ratio
$43.41
★ N/A
Revenue Growth
N/A
★ 36.75
52 Week Low
$30.05
$1.79
52 Week High
$45.90
$7.61

Technical Indicators

Market Signals
Indicator
FNWD
FHTX
Relative Strength Index (RSI) 61.46 25.12
Support Level $42.56 $1.79
Resistance Level $44.01 $5.27
Average True Range (ATR) 0.83 0.14
MACD 0.26 0.11
Stochastic Oscillator 95.15 61.43

Price Performance

Historical Comparison
FNWD
FHTX

About FNWD Finward Bancorp

Finward Bancorp is a bank holding company that engages in the provision of financial services. It offers products and services related to Personal Banking, Cash Management, Savings Account, ebanking, Wealth Management, and Insurance Services. It is engaged in the business of attracting deposits from the general public and the origination of loans, mostly upon the security of single-family residences and commercial real estate, construction loans, commercial business loans, and municipal loans. Geographically, the activities are carried out throughout the United States. The Company operates as a single reportable segment that derives its revenue mainly from the business of banking.

About FHTX Foghorn Therapeutics Inc.

Foghorn Therapeutics Inc is a clinical stage, precision therapeutics biotechnology company focused on pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression through selectively targeting the chromatin regulatory system. Its proprietary platform is designed to provide an integrated, mechanistic understanding of interactions within the chromatin regulatory system, supporting the identification and validation of potential therapeutic targets. The company's flagship program is FHD-909.

Share on Social Networks: